Advances with using CRISPR/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances with using CRISPR/Cas-mediated gene editing to treat infections with hepatitis B virus and hepatitis C virus

Published:2018-01 Issue: Volume:244 Page:311-320
ISSN:0168-1702
Container-title:Virus Research
language:en
Short-container-title:Virus Research

Author:

Moyo Buhle,Bloom Kristie,Scott Tristan,Ely Abdullah,Arbuthnot Patrick

Funder

South African National Research Foundation

Medical Research Council and Poliomyelitis Research Foundation

Johnson & Johnson Innovation and the Poliomyelitis Research Foundation (PRF)

Publisher

Elsevier BV

Subject

Cancer Research,Infectious Diseases,Virology

Reference112 articles.

1. 75 REP 9AC is a potent HBsAg release inhibitor which clears serum HBsAg and elicits SVRs in patients with chronic hepatitis B;Al-Mahtab;J. Hepatol.,2011

2. Proliferation of hepatitis B virus infected human hepatocytes in humanized mice treated with the entry inhibitor Myrcludex-B induces strong cccDNA reduction and maintenance of cccDNA-free hepatocytes;Allweiss;Z. Gastroenterol.,2014

3. ARB-1467 (RNAi);Arbutus BioPharma,2016

4. Novel Drugs to Treat Intractable Diseases;Arrowhead Pharmaceuticals,2016

5. Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages;Bility;PLoS Pathog.,2014

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Approaches to Inhibition of HBsAg Expression from cccDNA and Chromosomal Integrants: A Review;Journal of Clinical and Translational Hepatology;2023-09-19

2. Recent Advances Using Genetic Therapies Against Infectious Diseases and for Vaccination;Human Gene Therapy;2023-09-01

3. Emerging and potential use of CRISPR in human liver disease;Hepatology;2023-08-22

4. CRISPR/Cas-9 vector system: targets UL-39 and inhibits Simplexvirus humanalpha1 (HSV-1) replication in vitro;Cellular and Molecular Biology;2023-07-31

5. Hydrodynamic Delivery: Characteristics, Applications, and Technological Advances;Pharmaceutics;2023-03-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3